SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCity Lon Inv Regulatory News (CLIG)

Share Price Information for City Lon Inv (CLIG)

Share Price is delayed by 15 minutes
Get Live Data
443.00    10.00 (2.31%)
Bid:
440.00
Ask:
443.00
Spread: 3.00 (0.682%)
Market Cap: £218.72m
CLIG Live PriceLast checked at - London Stock Exchange

Intraday City Lon Inv Share Chart

Funds Under Management

8 Mar 2010 07:00

RNS Number : 1814I
City of London Investment Group PLC
08 March 2010
 



8 March 2010

CITY OF LONDON INVESTMENT GROUP PLC

("City of London" or "the Company")

 

FUNDS UNDER MANAGEMENT AS AT 26 FEBRUARY 2010

 

City of London Investment Group PLC (AIM: CLIG), a leading emerging market asset management group, announces its total funds under management (FuM) quarterly. As at 26 February 2010, the FuM were US$4.5 billion (£2.9 billion). This compares to US$4.7 billion (£2.9 billion) at the Company's half year end on 30 November 2009, US$3.5 billion (£2.3 billion) at the 31 May 2009 year end and US$2.2 billion (£1.5 billion) on 27 February 2009.

 

In dollar terms, the quarter on quarter decrease in FuM of 6.7% compares with a fall of 1.8% in the MSCI Emerging Markets Index (MXEF) during the same period, as client rebalancing led to approximately US$223 million of redemption activity, but it is notable that in sterling terms FuM has actually increased by 1.2% over the quarter as a result of sterling weakness. As referenced in the interim statement, this rebalancing was expected as a result of the significant recent outperformance of the emerging markets relative to global developed, and we have a healthy pipeline of potential clients and mandates through which to replace those assets. The year on year FuM increase at 101.0%, again in dollar terms, compares to an 87.4% rise in MXEF. The difference reflects net new mandates and out-performance.

 

One year ago we said that we were "unfashionably optimistic" regarding our asset class. As of today our view remains the same, though it can perhaps be said that this is now more closely reflected in mainstream opinion and market commentary. That is not to say that we were or have become complacent, and our commitment to growing our business through a cautious diversification program, primarily centered on the development of our established equities expertise, is undiminished. This program is long term, and while the progress that has been made is therefore hard to demonstrate, we are confident that shareholders and employees will be rewarded for their patience.

 

The interim dividend of 7 pence per share was paid last week, and with one quarter of our financial year to go, we anticipate that our one third/two thirds policy will be consistent with our target cover ratio for the current year, which would be slightly below the long term policy level of 1.5x.

 

For further information contact:

Doug Allison

Jeff Keating

Simon Hudson

Finance Director

Singer Capital Markets Ltd

Andrew Dunn

City of London Investment Group plc

Joint Broker

Tavistock Communications

Tel: 020 7711 0771

Tel: 020 3205 7500

Tel: 020 7920 3150

Chris Sim

Evolution Securities Limited

Joint Broker

Tel: 020 7071 4300

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCKKPDNPBKDANK
Date   Source Headline
20th Apr 20267:00 amRNSTrading Update for the quarter to 31 March 2026
7th Apr 20262:44 pmRNSPDMR Shareholding
31st Mar 20261:56 pmRNSEBT Share Purchase
26th Mar 202612:09 pmRNSEBT Share Purchase
25th Mar 202611:33 amRNSPDMR Shareholding
24th Mar 20269:56 amRNSEBT Share Purchase
13th Mar 20263:05 pmRNSPDMR Shareholding
10th Mar 20264:07 pmRNSEBT Share Purchase
10th Mar 20264:07 pmRNSEBT Share Purchase
9th Mar 202612:35 pmRNSPDMR Shareholding
4th Mar 202612:48 pmRNSGrant of LTIP Award
24th Feb 20267:00 amRNSHalf Year Results and Dividend Declaration
13th Feb 202611:00 amRNSInvestor Presentation
21st Jan 20267:00 amRNSAppointment of Chief Executive Officer
19th Jan 20267:00 amRNSTrading Update - Six months to 31 December 2025
29th Oct 20253:15 pmRNSPDMR/PCA Shareholding
29th Oct 20253:15 pmRNSPDMR Shareholding
29th Oct 20253:15 pmRNSPDMR Shareholding
29th Oct 20253:15 pmRNSPDMR Shareholding
27th Oct 20255:25 pmRNSResult of AGM
21st Oct 20255:00 pmRNSPDMR Shareholding
20th Oct 20257:00 amRNSTrading Update - Quarter to 30 September 2025
22nd Sep 20255:20 pmRNSCorrection: Final Results for year to 30 June 25
16th Sep 20257:00 amRNSFinal Results for the year to 30th June 2025
11th Sep 20257:00 amRNSInvestor Presentation via Investor Meet Company
5th Aug 20258:14 amRNSDirector Declaration
24th Jul 20257:00 amRNSPre-Close Trading Update
2nd Jul 20256:12 pmRNSBoard and Committee changes
1st Jul 202512:10 pmRNSDirector/PDMR Shareholding
17th Jun 20255:34 pmRNSDirector/PDMR Shareholding
13th Jun 20259:57 amRNSDirector/PDMR Shareholding
13th Jun 20259:47 amRNSHolding(s) in Company
10th Jun 20257:00 amRNSDirectorate Change
22nd Apr 20257:00 amRNSFUNDS UNDER MANAGEMENT 31 MARCH 25, TRADING UPDATE
7th Apr 20257:00 amRNSAPPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR
25th Feb 20257:00 amRNSHalf Year Results
20th Jan 20257:00 amRNSSIX MONTHS TO 31 DECEMBER 2024 TRADING UPDATE
29th Oct 20245:27 pmRNSPDMR Dealing
29th Oct 20245:27 pmRNSPDMR Dealing
29th Oct 20245:26 pmRNSPDMR Dealing
28th Oct 20245:57 pmRNSResult of AGM & Board change - Replacement
28th Oct 20244:14 pmRNSResult of AGM and Board and Committee change
21st Oct 20247:00 amRNSTRADING UPDATE - Quarter to 30 September 2024
17th Oct 20244:46 pmRNSHolding(s) in Company
16th Oct 20241:02 pmRNSHolding(s) in Company
11th Oct 20244:50 pmRNSHolding(s) in Company
24th Sep 20247:00 amRNSFINAL RESULTS FOR THE YEAR TO 30TH JUNE 2024
13th Sep 20242:54 pmRNSFull Year Results release date
25th Jul 20247:00 amRNSPRE-CLOSE TRADING UPDATE
23rd May 20244:32 pmRNSDirector Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.